Glioblastoma (GBM) is known as a tumor type, which arises from astrocytes. Several studies
indicated that GBM tumor cells are malignant. This is because of the fact that they consist of …

Substantial effort has been made over the last six decades to identify biomarkers for multiple
sclerosis that can improve disease diagnosis, predict disease progression, and improve …

In recent years, microRNAs (miRNAs) have gained increased attention from researchers
around the globe. Although it is twenty nucleotides long, it can modulate several gene …

For many neurological diseases, the efficacy and outcome of treatment depend on early
detection. Diagnosis is currently based on the detection of symptoms and neuroimaging …

Diagnosis of multiple sclerosis (MS) requires the exclusion of other possible diagnoses. For
this reason, the cerebrospinal fluid (CSF) should be routinely analysed in patients with a first …

Many neurodegenerative diseases, such as Alzheimer's disease, Parkinson disease,
vascular and frontotemporal dementias, as well as other chronic neurological pathologies …

There has been a growing interest in using next-generation sequencing (NGS) to profile
extracellular small RNAs from the blood and cerebrospinal fluid (CSF) of patients with …

MicroRNAs (miRNAs) are evolutionally conserved, single-stranded RNAs that regulate gene
expression at the posttranscriptional level by disrupting translation. MiRNAs are key players …

The advent of highly effective disease modifying therapy has transformed the landscape of
multiple sclerosis (MS) care over the last two decades. However, there remains a critical …

MicroRNAs (miRNAs) are single-stranded 19-25 nucleotide-long RNAs and have an
important role in post-transcriptional gene silencing. It has been demonstrated that miRNAs …